Suchergebnisse - "Follmann, Dean"

PubPharm (326)

71

How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19

enthalten in: Annals of internal medicine | 2021

von Proschan, M. | Follmann, D. | Dodd, L.

CommentOn: Ann Intern Med. 2020 Oct 20;173(8):632-637. - PMID 32634024

72

How many COVID-19 PCR positive individuals do we expect to see on the Diamond Princess cruise ship?

enthalten in: bioRxiv.org | 2021

von Qin, J. | Chen, F. | Ma, H. | +3

73

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

enthalten in: Annals of internal medicine | 2021

von Mehrotra, D. | Janes, H. | Fleming, T. | +25

74

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

enthalten in: The New England journal of medicine | 2021

von Simonovich, V. | Burgos Pratx, L. | Scibona, P. | +137

75

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

enthalten in: The New England journal of medicine | 2021

von Baden, L. | El Sahly, H. | Essink, B. | +135

CommentIn: N Engl J Med. 2021 Feb 4;384(5):470-471. - PMID 33378607

76

Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis

enthalten in: Science translational medicine | 2021

von Xie, Y. | de Jager, V. | Chen, R. | +21

77

Two Stage Designs for Phase III Clinical Trials

enthalten in: bioRxiv.org | 2021

von Follmann, D. | Proschan, M.

78

enthalten in: Statistics in Medicine | 2021

von Follmann, D.

79

The mechanistic analysis of founder virus data in challenge models

enthalten in: Statistics in Medicine | 2021

von Ortega‐Villa, A. | Nason, M. | Follmann, D.

80

Assessing vaccine durability in randomized trials following placebo crossover

enthalten in: Statistics in Medicine | 2021

von Fintzi, J. | Follmann, D.